Cargando…
Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
Curative surgical treatments, mainly liver resection, are still one of the optimal options for patients with early-, mid-, and even progression-stage hepatocellular carcinoma (HCC). However, the recurrence rate within 5 years after surgery is as high as 70%, especially in patients with high risk fac...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149944/ https://www.ncbi.nlm.nih.gov/pubmed/37139151 http://dx.doi.org/10.3389/fonc.2023.1098958 |